We use cool technologies to treat dangerous cardiac arrhythmias and other disorders.
We are currently focused on treating atrial fibrillation, the most common cardiac arrhythmia which affects over 6 million patients in the US alone, and costs the US economy over $26B annually. Currently, treatments are sub-optimal, and have significant side effects and pain associated with them. By cooling the heart gently, we may be able to terminate this dangerous arrhythmia in a painless manner at a point of care that is better for patients, providers, and the healthcare ecosystem.
